Direxion Daily S&P Biotech Bull 3X Shares
LABU
LABU
14 hedge funds and large institutions have $23.2M invested in Direxion Daily S&P Biotech Bull 3X Shares in 2018 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
6% less capital invested
Capital invested by funds: $24.6M → $23.2M (-$1.4M)
37% less call options, than puts
Call options by funds: $40.4M | Put options by funds: $64.1M
67% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 6
Holders
14
Holding in Top 10
1
Calls
$40.4M
Puts
$64.1M
Top Buyers
1 | +$3.79M | |
2 | +$927K | |
3 | +$535K | |
4 |
Citigroup
New York
|
+$104K |
5 |
UBS Group
Zurich,
Switzerland
|
+$90K |
Top Sellers
1 | -$6.02M | |
2 | -$2.39M | |
3 | -$2.37M | |
4 |
Citadel Advisors
Miami,
Florida
|
-$618K |
5 |
EWA
Exencial Wealth Advisors
Oklahoma City,
Oklahoma
|
-$207K |